Precursor Condition
Cervical Intraepithelial Neoplasia Grade 2/3
CI-CAN-00004785Explore in graph →
Precursor9 active trials
- NCIt
- C94676
Loading cancer entity…
Precursor Condition
CI-CAN-00004785Explore in graph →
Clinical trials
29 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04484415 | Efficacy and Safety of Cevira® in Patients With Cervical Histologic High-grade Squamous Intraepithelial Lesions (HSIL)(APRICITY) | unknown | Phase 3 | 402 | Asieris MediTech (Hong Kong) Co., Ltd.INDUSTRY | 1 | Aug 12, 2022 | clinicaltrials |
| NCT03366493 | The Study of Folate Receptor-Mediated Staining Solution (FRD™) In Cervical Lesion Detection | unknown | Phase 3 | 200 | GY Highland Biotech LLCINDUSTRY | 1 | Dec 8, 2017 |
| clinicaltrials |
Data updated 23 days agoSource updated Aug 12, 2022source: clinicaltrials